Clinical Trial Update: A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic). [Phase 3]

View source ↗

Summary

Phase 3 study of TAS-102 (trifluridine/tipiracil) in pretreated metastatic colorectal cancer has completed; this document provides an update on the trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: COMPLETED